Leprosy Laboratory, Oswaldo Cruz Institute-Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil.
PROCC-Programa de Computação Científica-Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil.
PLoS Negl Trop Dis. 2019 Mar 5;13(3):e0007147. doi: 10.1371/journal.pntd.0007147. eCollection 2019 Mar.
The diagnosis of paucibacillary (PB) leprosy cases remains a challenge because of the absence of a confirmatory laboratory method. While quantitative polymerase chain reaction (qPCR) has been shown to provide reliable sensitivity and specificity in PB diagnoses, a thorough investigation of its efficacy in clinical practice has not yet been published. The present study evaluated patients with suspected leprosy skin lesions by using qPCR to identify PB individuals in the Leprosy Outpatient clinic at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil.
One hundred seventy-two suspected PB cases were included in the study. The patients were evaluated by a dermatologist at three different times. The clinical dermato-neurological examination and collected samples were performed on the first visit. On the second visit, the results of the histopathological analysis and PCR assay (DNA-based Mycobacterium leprae qPCR-targeting 16S gene) results were analyzed, and a decision regarding multi-drug therapy was made. A year later, the patients were re-examined, and the consensus diagnosis was established.
In 58% (100/172) of cases, a conclusive diagnosis via histopathological analysis was not possible; however, 30% (30/100) of these cases had a positive PCR. One hundred ten patients (110/172) attended the third visit. The analysis showed that while the sensitivity of the histopathological test was very low (35%), a qPCR alone was more effective for identifying leprosy, with 57% sensitivity.
The use of qPCR in suspected PB cases with an inconclusive histology improved the sensitivity of leprosy diagnoses.
由于缺乏确证性实验室方法,少菌型(PB)麻风病的诊断仍然具有挑战性。虽然定量聚合酶链反应(qPCR)已被证明在 PB 诊断中具有可靠的灵敏度和特异性,但尚未发表对其在临床实践中的疗效进行的全面调查。本研究通过 qPCR 评估了巴西里约热内卢 Oswaldo Cruz 基金会麻风病门诊的疑似麻风皮损患者,以确定 PB 个体。
本研究纳入了 172 例疑似 PB 病例。皮肤科医生在三个不同时间对患者进行评估。首次就诊时进行临床皮肤神经科检查和采集样本。第二次就诊时,分析组织病理学分析和 PCR 检测(基于 DNA 的麻风分枝杆菌 16S 基因 qPCR 检测)结果,并决定是否进行多药治疗。一年后,对患者进行重新检查,并建立共识诊断。
在 58%(100/172)的病例中,通过组织病理学分析无法得出明确的诊断;然而,其中 30%(30/100)的病例 PCR 呈阳性。110 例患者(110/172)参加了第三次就诊。分析表明,虽然组织病理学检测的灵敏度非常低(35%),但单独使用 qPCR 对麻风病的识别更有效,灵敏度为 57%。
在组织学不确定的疑似 PB 病例中使用 qPCR 提高了麻风病诊断的灵敏度。